{"id":"W4416013423","doi":"10.1186/isrctn13202059","title":"Switching to the IL-23 inhibitor guselkumab for people with active inflammatory bowel disease (IBD) who previously used ustekinumab (SHIFT-IBD)","year":2025,"lang":"","type":"dataset","venue":"http://isrctn.com/","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Canada","keywords":"Ustekinumab; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Disease; Psoriasis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","scholarly_communication","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.005481309,0.008977445,0.007693133,0.003742581,0.006401035,0.004683733,0.01179419,0.002952299,0.0005532331],"category_scores_gemma":[0.005548749,0.007492618,0.003514503,0.00618851,0.001187274,0.003973956,0.00679758,0.008101637,0.005710908],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007295462,"about_ca_system_score_gemma":0.01445666,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001639205,"about_ca_topic_score_gemma":0.02769692,"domain_scores_codex":[0.9641225,0.003971849,0.006537252,0.009685756,0.007151416,0.008531225],"domain_scores_gemma":[0.9640835,0.005639832,0.00641263,0.01562923,0.002655942,0.005578865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03271091,0.003148207,0.001579196,0.01065204,0.005515563,0.0005985792,0.01449978,0.003134013,0.0002398259,0.0006964992,0.925361,0.001864338],"study_design_scores_gemma":[0.01833594,0.002909098,0.007777014,0.01980167,0.01274042,0.00008940227,0.003969567,0.005203499,0.0005521364,0.0003222282,0.9185916,0.009707391],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.07272331,0.002248739,0.00213187,0.004456589,0.005029086,0.04075867,0.8711732,0.001345051,0.0001335131],"genre_scores_gemma":[0.1172383,0.0008565882,0.0007493044,0.003590253,0.006596216,0.02420793,0.8388473,0.003186963,0.004727168],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.04451494,"threshold_uncertainty_score":0.9983421,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01023219722796826,"score_gpt":0.2544778597874771,"score_spread":0.2442456625595089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}